Therapeutic effects of the Anacardiaceae family on experimental diabetes mellitus: a scoping review
Comparative Clinical Pathology · 04.07.2026 · 35 (1)
DOI: 10.1007/s00580-026-03817-8 ↗Kurz gefasst
Scoping Review in der Zeitschrift Comparative Clinical Pathology, online erschienen am 04.07.2026. Verfasst von Letícia Alves Borges e Pires und 6 weiteren Autor:innen. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal Do Rio Grande Do Norte.
Themen: Diabetes mellitus
Abstract (Originalsprache)
This study aimed to investigate the therapeutic potential of species from the Anacardiaceae family in experimental diabetes mellitus. The scoping review was conducted following the Joanna Briggs Institute (JBI) methodology and reported according to the PRISMA Extension for Scoping Reviews (PRISMA-ScR). The protocol was registered in the Open Science Framework (OSF), and the search was conducted across PubMed/MEDLINE, Scopus, Web of Science, and EMBASE, as well as Google Scholar and ProQuest, with no language or publication date restrictions. Studies involving rodent models of experimental diabetes mellitus treated with species from the Anacardiaceae family were included. Exclusion criteria comprised studies involving non-rodent animals, studies not related to both Anacardiaceae and experimental diabetes mellitus, and those involving synthetic therapies already available on the market. Among the 51 articles evaluated, the first study associating the Anacardiaceae family with experimental diabetes mellitus was published in 2004. Streptozotocin was used in 62.7% of the studies, and species such as Anacardium occidentale (cashew) and Mangifera indica (mango) were the most frequently studied. Tissue analysis was performed in 47% of the studies, while biochemical analyses were carried out in 92%. In conclusion, species from the Anacardiaceae family demonstrate promising antidiabetic effects in experimental models, highlighting the therapeutic potential of Brazilian flora as a source of bioactive compounds for diabetes management. Further studies are needed to confirm their efficacy and safety.
Förderung
- Universidade Federal Do Rio Grande Do Norte
Zitieren
APA
Pires, L. A. B. E., Silva, C. P. C. D., Sena, V. N. F. D., Abreu, B. J., Silva, F. S., Taveira, K. V. M., & Medeiros, K. C. D. P. (2026). Therapeutic effects of the Anacardiaceae family on experimental diabetes mellitus: a scoping review. Comparative Clinical Pathology, 35(1). https://doi.org/10.1007/s00580-026-03817-8
Vancouver
Pires LABE, Silva CPCD, Sena VNFD, Abreu BJ, Silva FS, Taveira KVM, et al. Therapeutic effects of the Anacardiaceae family on experimental diabetes mellitus: a scoping review. Comparative Clinical Pathology. 2026;35(1). doi:10.1007/s00580-026-03817-8
BibTeX
@article{Pires2026,
author = {Pires, Letícia Alves Borges e and Silva, Cecília Paulino Cassiano da and Sena, Vitória Natália Ferreira de and Abreu, Bento João and Silva, Flávio Santos and Taveira, Karinna Veríssimo Meira and Medeiros, Karina Carla de Paula},
title = {Therapeutic effects of the Anacardiaceae family on experimental diabetes mellitus: a scoping review},
journal = {Comparative Clinical Pathology},
year = {2026},
volume = {35},
number = {1},
doi = {10.1007/s00580-026-03817-8}
}
EUVIMED